医学
最小临床重要差异
强度(物理)
物理疗法
癌症疼痛
缓和医疗
止痛药
前瞻性队列研究
癌症
内科学
随机对照试验
麻醉
麻醉学
护理部
物理
量子力学
作者
Sebastiano Mercadante,Claudio Adile,Federica Aielli,Gaetano Lanzetta,Kyriaki Mistakidou,Marco Maltoni,Luiz Guilherme Soares,Stefano DeSantis,Patrizia Ferrera,Marta Rosati,R Rossi,Alessandra Casuccio
出处
期刊:Pain Medicine
[Oxford University Press]
日期:2019-09-20
卷期号:21 (2): e215-e221
被引量:13
摘要
Abstract Objective To assess the personalized pain intensity goal (PPIG), the achievement of a personalized pain goal response (PPGR), and patients' global impression (PGI) in advanced cancer patients after a comprehensive pain and symptom management. Design Prospective, longitudinal Setting Acute pain relief and palliative/supportive care. Subjects 689 advanced cancer patients. Methods Measurement of Edmonton Symptom Assessment Score (ESAS) and personalized pain intensity goal (PPIG) at admission (T0). After a week (T7) personalized pain goal response (PPGR) and patients' global impression (PGI) were evaluated. Results The mean PPIG was 1.33 (SD 1.59). A mean decrease in pain intensity of − 2.09 was required on PPIG to perceive a minimal clinically important difference (MCID). A better improvement corresponded to a mean change of − 3.41 points, while a much better improvement corresponded to a mean of − 4.59 points. Patients perceived a MCID (little worse) with a mean increase in pain intensity of 0.25, and a worse with a mean increase of 2.33 points. Higher pain intensity at T0 and lower pain intensity at T7 were independently related to PGI. 207 (30.0%) patients achieved PPGR. PPGR was associated with higher PPIG at T0 and T7, and inversely associated to pain intensity at T0 and T7, and Karnofsky level. Patients with high pain intensity at T0 achieved a favorable PGI, even when PPIG was not achieved by PPGR. Conclusion PPIG, PPGR and PGI seem to be relevant for evaluating the effects of a comprehensive management of pain, assisting decision-making process according to patients' expectations. Some factors may be implicated in determining the individual target and the clinical response.
科研通智能强力驱动
Strongly Powered by AbleSci AI